BDMD
Baird Medical Investment Holdings Limited
NASDAQ: BDMD · HEALTHCARE · MEDICAL DEVICES
$1.72
+0.58% today
Updated 2026-04-30
Market cap
$67.58M
P/E ratio
—
P/S ratio
3.00x
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$1 – $7
Volume
1.5M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F4.0
Quality
C2.0
Profitability
F6.7
Valuation
B1/9
Piotroski F-Score
Weak
0.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
$2.63
Margin of safety
+68.08%
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $1.85M — positive
+ 68.08% below intrinsic value
Risks
- Piotroski 1/9 — weak financial health
- Altman Z 0.72 — distress zone
- Thin margins at -121.00%
- Revenue declining -39.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $35.09M | $31.46M | $37.04M | $22.54M | $22.54M |
| Net income | $12.57M | $10.55M | $12.45M | $-27.28M | $-15.98M |
| EPS | — | — | — | — | $-0.11 |
| Free cash flow | $-5.47M | $-3.66M | $-9.17M | $-1.39M | $1.85M |
| Profit margin | 35.82% | 33.52% | 33.62% | -121.04% | -121.00% |
Peer comparison
Smart narrative
Baird Medical Investment Holdings Limited trades at $1.72. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 0.72, it sits in the distress. TTM revenue stands at $22.54M. with profit margins at -121.00%. Our DCF model estimates intrinsic value at $2.63.
Frequently asked questions
What is Baird Medical Investment Holdings Limited's stock price?
Baird Medical Investment Holdings Limited (BDMD) trades at $1.72.
Is Baird Medical Investment Holdings Limited overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell). DCF value $2.63.
What is the price target of Baird Medical Investment Holdings Limited (BDMD)?
The analyst target price is $—, representing NaN% downside from the current price of $1.72.
What is the intrinsic value of Baird Medical Investment Holdings Limited (BDMD)?
Based on our DCF model, intrinsic value is $2.63, a +68.1% margin of safety versus $1.72.
What is Baird Medical Investment Holdings Limited's revenue?
TTM revenue is $22.54M.
Piotroski F-Score?
1/9 — weak financial health.
Altman Z-Score?
0.72 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.00x
ROE-77.60%
Beta-1.16
50D MA$2.03
200D MA$1.84
Shares out0.04B
Float0.01B
Short ratio—
Avg volume1.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—